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The gastrointestinal tract harbors a wide array of smooth muscle cells, motor 
neurons, and epithelial and stem cells. This makes it an attractive model system for 
the study of regeneration following mechanical injury. This project investigated the 
regenerative capacity of the gut by injuring the murine gastrointestinal tract and 
characterizing the changes that occur in several cell populations critical to 
gastroenterological function. To accomplish this, a chronic partial intestinal 
obstruction surgery was used to stimulate intestinal tissue, and changes to cellular 
phenotype and behavior were characterized using histology and 
immunofluorescence. We found that the injury induced smooth muscle 
hypertrophy, which involved the proliferation of CD34+/CD29-/CD45+ cells. 
Moreover, mature smooth muscle cells dedifferentiated into a proliferative, 
PDGFRα+ phenotype under hypertrophic and cultured conditions. Future directions 
will evaluate the potential of these cells for use in cell therapy, and will translate 
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In humans and mice, the gastrointestinal (GI) tract is a smooth muscle-lined 
organ responsible for breaking down and absorbing nutrients (Sanders et al. 2012). 
Rhythmic contraction of GI smooth muscle cells (SMC) is necessary for successful 
elimination of waste, and is coordinated by motor neurons named interstitial cells of 
Cajal (ICC). In addition to ICC-based electrical signals, GI peristalsis is coordinated 
by a series of ion channels and SMC mechanosensors. The GI tract also contains a 
population of platelet derived growth factor receptor alpha (PDGFRα)-expressing 
cells, which are implicated in anchoring epithelial tissues to their surrounding 
organs and serve a heretofore-unknown function (Betsholtz et al. 2001).  
Due to the intricate relationship between SMC, ICC, and PDGFRα cells, it is 
unsurprising that many human GI disorders result from dysfunction in these cell 
types (Grover et al. 2012). One disorder of interest is the chronic partial intestinal 
obstruction, which results from physical blockage of the gastrointestinal tract and 
causes hernia, severe pain, and can be fatal if untreated for prolonged periods of 
time (Agresta et al. 1999). One mouse model of this disorder has shown that GI 
injury drives ICC to dedifferentiate or transdifferentiate into a SMC-like cell 
population (Chang et al. 2001). This report suggests that the partial obstruction 
(PO) prevents maintenance of adult ICC phenotype in a way that interferes with the 
proper functioning of GI tissue.  
To better understand the impact of this ICC-deficient disorder on GI 
functioning, our group sought to expand the partial obstruction model used by 
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Chang et al. (2001) with a focus on the behavior of SMC and PDGFRα cells. Using 
histology and immunofluorescence experiments, we showed that PO reduces the 
numbers of SMC and ICC and results in a large population of proliferative stem cell-
like cells, and that this change appeared to be driven by a hypertrophic or 
inflammatory mechanism. Fate mapping revealed that some of these proliferative 
cells were derived from SMC and had been induced to express low levels of PDGFRα. 
Cell culture demonstrated that SMC could be induced to dedifferentiate into 
proliferative PDGFRα cells in vitro.  We screened these proliferative cells for other 
markers and found that they express a high number of mesenchymal stem cell 
antigens. We are continuing these immunofluorescence experiments to detect 
changes in other major GI antigens following injury, to acquire a more 
comprehensive picture of which cell types are implicated in the injury-response. 
Taken together, this project has expanded our understanding of SMC biology by 
uncovering a specific pathway through which mature GI populations respond to 
mechanical injury.  
Moving forwards, we will take data from our laboratory’s smooth muscle 
transcriptome browser (not yet published) to determine which proteins are most 
likely upregulated during injury. Our preliminary data suggests that proteins altered 
during injury will be related to ICC functionality, such as thrombospondin 4 
(THBS4), cKIT, ANO1, PGP9.5.  Since injury results in an increase in the number of 
proliferative cells, we also predict upregulation of stem cell antigens such as CD29, 
CD34, and CD45. Finally, we intend to investigate expression of transcription factors 
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known to induce phenotypic switching, such as MyoD. Changes in the expression or 
localization of these proteins will allow us to hypothesize a mechanism through 
which the partial obstruction injury alters intestinal cell phenotype.  
 
Methods 
Generation of transgenic mouse lines. 
To track the behavior of SMC following dedifferentiation, we aimed to 
generate a Cre-Stop-Lox mouse line. To this end, we purchased smMHCiCre-ERT2/+ and 
Rosa26lacZ/lacZ mice from Jackson Laboratories and mated them. At 3 weeks of age, 
tamoxifen injections were given to induce iCre activity, which permitted lacZ 
expression in mice that were expressing the smMHC promoter at that time. 
Tamoxifen injections were performed again at 4 and 6 weeks of age. This enabled 
generation of mice that permanently expressed lacZ in cells that had previously 
expressed the smooth muscle myosin heavy chain (smMHC) marker. We are 
currently optimizing the age at which mice receive tamoxifen injection to ensure 
that the largest number of smMHC-expressing cells are induced to express lacZ. 
 
Partial obstruction surgery model 
Two weeks after receiving their first tamoxifen injection, mice were subject 
to our partial obstruction surgery, which was adapted from Chang et al. (2001). This 
protocol currently has IRB approval. Mice were anesthetized using isoflurane, and a 
synthetic ring was inserted around the distal ileum of the animal’s GI tract in a 
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recovery surgery. Age-matched control mice were given a sham surgery in which 
the intestines were manipulated using forceps, but no synthetic ring was applied. 
Mice were sacrificed after two weeks. 
 
Tissue preparation 
For tissue extraction, mice were anesthetized using isoflurane and the animal 
was killed by displacement of the cervical spine. Intestines were fixed in 4% 
paraformaldehyde/PBS for 80 minutes at 4°C and briefly washed in TBS. To 
dehydrate the intestines for freezing, the fixed GI was then incubated overnight in 
20% sucrose in PBS at room temperature. The intestines were then flash-frozen in a 
cryosectioning reagent (33% Optimal Cutting Temperature Compound in 20% 
sucrose in PBS). Flash-freezing was conducted by immersing the tissue in 95% 
ethanol that had been chilled by liquid nitrogen. Molds were then cryosectioned at 
negative 20°C to generate slides. 
 
Immunohistochemistry 
Cryosectioned slides were air dried for 15 minutes before being washed 
twice in TBS for 5 minutes. Slides were then immersed in 0.1% Tween-20/TBS 
before a 15-minute incubation with egg whites to block endogenous avidin. To block 
nonspecific binding, tissues were incubated with 4% dry milk and 0.01% Tween-20 
in TBS. Tissues were then incubated overnight at 4°C with the associated antibody 
at a concentration specified by the manufacturer of the antibody in 4% dry milk and 
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0.01% Tween-20 in TBS. The next day, slides were washed three times for one 
minute each in TBS before being incubated for one hour with secondary and biotin-
conjugated antibody at a concentration specified by the manufacturer in 4% dry 
milk and 0.01% Tween-20 in TBS. Slides were then washed three more times for 
one minute each in TBS before being incubated with 594-conjugated streptavidin 
for one hour at a concentration of 1:450 in 4% dry milk and 0.01% Tween-20 in 
TBS. Slides were then washed five times for one minute each in TBS. After drying for 
one hour, slides were coverslipped using Invitrogen Prolong DAPI Coverslipping 
Reagent (Invitrogen). Slides were cured overnight at room temperature and sealed 
using nail polish purchased at Walmart. 
 
Hematoxylin and Eosin Staining 
Slides were washed in deionized water for 1 minute before being treated 
with hematoxylin for 90 seconds. Slides were then washed a second time in 
deionized water before being treated with eosin for 30 seconds. Slides were then 
put through a dehydration gradient of absolute ethanol, 90% ethanol in water, 80% 
ethanol in water, 70% ethanol in water, and xylene for 10 minutes each. Samples 
were the air-dried for 10 minutes and coverslipped using Permount (Fisher). 
 
X-gal Staining 
Cryosectioned samples were treated with 5-bromo-4-chloro-3-indolyl β-d-
galactosidase using the β-gal Staining Kit (Life Technologies). The protocol was 
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modified so that samples were incubated overnight at 37°C in a humidified chamber 
before removal of the β-galactosidase reagent. This resulted in stronger LacZ 
labeling.   
 
Results 
Partial Obstruction Surgery Results in Severe Morphological Changes 
The partial obstruction surgery resulted in gross distension of the intestines 
from the duodenum through the cecum (Fig 1a-b). H&E imaging revealed that 
hypertrophy occurred throughout all layers of the submucosa, mucosa, and 
muscularis, but was most significant in the circular muscle and serosa (Fig 1c-f).  
 
Hypertrophic Tissue Has Non-Native Origin 
X-gal labeling marked both muscularis layers, and light staining was 
observed in the serosa (Figure 2a-b). Immunofluorescence labeling of LacZ revealed 
that numerous LacZ+ cells were present in the intestinal serosa (Fig 2c). High 
magnification images of the serosa confirmed that virtually none of the LacZ-
expressing cells maintained Myh11 expression (Fig 2d-e). While these LacZ-
expressing cells were largely Ki67+, there were also a large number of serosal cells 





Partial Obstruction-Induced Cells are Proliferative and PDGFRα + 
To establish the current identity of the LacZ-; Ki67+ cells, we generated a 
PDGFRα-GFP expressing mouse line and subject the animals to partial obstruction 
surgeries. We found that the majority of the cells in the serosa were PDGFRα+ as 
indicated by GFP expression; virtually all of these co-expressed Ki67 and CD45 (Fig 
3a). We screened these cells for common stem cell markers and found that they are 
negative for the mesenchymal stem cell marker CD29, but express high levels of the 
hematopoietic stem cell marker CD34 (Fig 3b-c). 
 
PDGFRα-Expressing Cells can be Converted to Smooth Muscle Cells in Vitro 
When PDGFRα-GFP cells were cultured, they proliferated over several days 
and quickly reached confluence (Fig 4b). While these cells were initially GFP-, they 
gained expression of this reporter and their morphology slowly became elongated. 
Conversely, culture of SMC-GFP cells lost GFP expression over the course of time 
(Fig 4a). The increase in GFP expression and change in shape both indicate the 
adoption of a differentiated state.  
 
Discussion 
Our gross partial obstruction data are consistent with previous findings, and 
our H&E stains revealed that SMCs are significantly impacted by the injury (Fig 1b). 
Our immunofluorescence experiments demonstrated that while the cells populating 
the injured area associated with SMCs, they do not express SMC-specific markers 
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and have strong proliferative character (Fig 2). These findings indicate that SMCs 
cannot independently account for the injury-response phenotype. 
We performed further immunofluorescence experiments to establish an 
identity for the injury-associated cells, and found that they express low levels of the 
protein Platet Derived Growth Factor Receptor Alpha (PDGFRα). The Platelet 
Derived Growth Factor (PDGF) ligand has long been associated with induction of 
target cells following mechanical injury, so it is not surprising to see PDGFRα-
expressing in the partial obstruction injury (Jawien et al. 1992). Their Ki67 
expression strongly suggest that they behave in this context as stem cells which 
drive a response to the injury (Fig 3).  
To further investigate the idea that PDGFRα cells act as stem cells, we 
isolated them from PDGFRα-GFP mice and cultured them. Their initial expression of 
Ki67 and high proliferation rate (determined by number of nuclei) when cocultured 
with smooth muscle growth factors strongly suggests a stem cell identity (Fig 4b). 
Further, they were able to convert into Myh11 expressing cells over time, indicating 
a role consistent with that of a smooth muscle stem cell (Fig 4a). The reduction of 
both Srf and Myh11 expression indicates the loss of mature SMC phenotype, 
suggesting that the cells have adopted a primitive and proliferative lineage (Fig 4c). 
This idea is recapitulated by the loss of Myocd and Elk1 transcription, which are 
both well-known vascular smooth muscle markers.   
Taken together, we have expanded on previous literature by identifying a 
specific class of cell that could drive an intestinal injury-response mechanism. 
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Further experiments should investigate whether this phenomenon occurs in human 









































Figure 1. a-b, Gross morphology of the small intestines from the stomach to the 





















Figure 2. a-b, X-gal imaging of wild type (a) and partial obstruction (b) tissue at 
40x; scale bar = 10µm. c, Confocal microscopy of partial obstruction tissue at 40x 
with DAPI and antibodies against LacZ (red) and smMHC (green); scale bar = 40µm. 






Figure 3. a, Confocal microscopy of sham and partial obstruction surgeries at 40x 
reveals differential LacZ and PDGFRα expression; scale bar = 30µm. b, Confocal 
microscopy at 40x reveals low levels of CD29 expression in partially obstructed 
serosa; scale bar = 30µm. c, Confocal microscopy at 40x reveals elevated levels of 





Figure 4. Cultured SMCs adopt stem-cell like, PDGFR-expressing character. a, 
culture of MYH11-GFP cells in smooth muscle growth medium. b, culture of 
PDGFRα-GFP cells in smooth muscle growth medium. c, QPCR analysis of Srf and 
Myh11 transcription levels over different days of SMC culture. d, QPCR analysis 
Myocd and Elk1 transcription levels over different days of culture. S = sham, PO = 
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